Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
- Status
- COMPLETED
- Phase
- PHASE2
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
- Status
- COMPLETED
- Phase
- PHASE2
18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Continued Access to RXDX-105
- Status
- COMPLETED
- Phase
- PHASE1
European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor
- Status
- COMPLETED
- Phase
- N/A
Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Acupressure for Fatigue in Ovarian Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
- Status
- UNKNOWN
- Phase
- PHASE1
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.
- Status
- COMPLETED
- Phase
- PHASE4
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1